Korytkova 2, 1000 Ljubljana
+386 1 543 7103
tajnistvo.patologija@mf.uni-lj.si
Osveži iskanje
Raziskovalni
Čugura T, Boštjančič E, Uhan S, Hauptman N, Jeruc J
Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma.
Experimental and molecular pathology 2024; 138: 1-12.
2.8
Draškovič T, Ranković, B, Zidar N, Hauptman N (avtor, korespondenčni avtor).
Upregulation of ABLIM1 differentiates intrahepatic cholangiocarcinoma from hepatocellular carcinoma and both colorectal and pancreatic adenocarcinoma liver metastases.
Genes. 2024, vol. 15, iss. 12, [article no.] 1545, str. 1-15.
Draškovič T, Ranković B, Zidar N, Hauptman N (avtor, korespondenčni avtor
DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases.
Clinical epigenetics. Nov. 2024, vol. 16, no. 1, [article no.] 153, str. 1-15, ilustr. ISSN 1868-7083.
4.8
Hribar M, Fošnarič I, Matos A, Šifrer R, Zidar N, Strojan P, Jenko K.
Clinical characteristics and outcomes of an institutional series of tympanomastoid paragangliomas from Slovenia.
Cancers 2024; 6(18):3178.
4.5
Pregledni
Drnovšek J, Homan M, Zidar N, Šmid LM.
. Pathogenesis and potential reversibility of intestinal metaplasia – a milestone in gastric carcinogenesis.
Radiol Oncol 2024; 21;58(2):186-195.
2.1
Bradley PJ, Stenman G, Thompson LDR, Skálová A, Simpson RHW, Slootweg PJ, Franchi A, Zidar N, Nadal A, Hellquist H, Williams MD, Leivo I, Agaimy A, Ferlito A.
Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland.
Virchows Arch 2024; 485(1):3-11.
3.4
Nadal A, Cardesa A, Agaimy A, Almangush A, Franchi A, Hellquist H, Leivo I, Zidar N, Ferlito A.
Massive parallel sequencing of head & neck squamous cell carcinomas: Part I: Conventional (non-HPV-associated) squamous cell carcinomas.
Virchow Arch 2024; 485(6):965-976.
Feakins R, Borralho Nunes P, Driessen A, Gordon IO, Zidar N, Baldin P, Christensen B, Danese S, Herlihy N, Iacucci M, Loughrey MB, Magro F, Mookhoek A, Svrcek M, Rosini F.
Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper.
J Crohns Colitis 2024; 18(2):175-191.
8.3
Portugal‑Gaspar F, Lopez‑Beltran A, Paner GP, Blanca A, Gómez Gómez E, Montironi R, Cimadamore A, Bilé A, Volavšek M, Cheng L.
Giant cell carcinoma of the urinary bladder. Clinicopathologic analysis and oncological outcomes.
Virchows Archiv 2024; 485:535–546.
Pukl M, George M, Javanmardi A, Carraro A, Korbelik J, White R, Macaulay CE, Palčič B, Keyes M, Volavšek M, Guillaud MD.
DNA ploidy as a potential adjunct prognostic marker of low-risk prostate cancer progression after radical prostatectomy.
Urology journal 2023; 20: 1-10.
0.6
Accessibility Tools